First, deficiency of the apoe or ldlr gene and STZ treatment result in extreme hyperlipidemia and hyperglycemia, respectively, and may result in overestimation of the contribution of hyperglycemia to diabetic complications. Here, LDLR is linked to hyperlipidemia.